Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab
===================================================================================================================================================================

* Anna K Maloney
* Anita Giobbie-Hurder
* Nikita Katukota
* Miklos C Fogarasi
* Patrick A Ott
* F Stephen Hodi
* Tamara A Sussman
* Ann W Silk
* Rizwan Haq
* David Liu
* Megan Insco
* Elizabeth I Buchbinder